Pharmacy Benefits Management (PBM)
PBM companies and pharmacy benefit technology platforms managing prescription drug benefits for health plan sponsors.
- 4
- Verticals
Overview
Pharmacy Benefits Management (PBM) covers companies and platforms managing prescription-drug benefits for health-plan sponsors — formulary design, negotiation, rebates, and claims adjudication. The market is a tight oligopoly: CVS Caremark, Express Scripts (Cigna), and OptumRx (UnitedHealth) control the vast majority, each vertically integrated with a major insurer.
PBMs sit at the center of drug-pricing flows, and their rebate and spread-pricing models have drawn intense FTC, Congressional, and state scrutiny and reform proposals. Reported revenue is large because drug costs flow through PBMs; the value-add is the management spread and rebate economics.
Market snapshot
- Market size
- ~$284B
- Growth
- ~9.9%CAGR (2017–22, nominal)
- Companies
- ~2,467 firms
68.4% of firms have fewer than 20 employees: 1,687 micro-businesses, below most mandates.
- 20–99
- 43456%
- 100–499
- 17522%
- 500+
- 17122%
revenue largely reflects drug-cost pass-through, not value-add.
NAICS 524292. U.S. Census Bureau — 2022 Statistics of U.S. Businesses; U.S. Census Bureau — 2022 Economic Census.
Business model & economics
Revenue model
Management fees, rebates, and spread on drug flows
Key economics
- Revenue per firm
- $114,938,828
- Revenue per employee
- $640,210
- Employees per firm
- 178.3
- Recurring revenue
- High
- EBITDA margin
- Thin on gross flows; concentrated in rebate/spread economics
- Capex intensity
- Low
multi-year benefit-management contracts
Characteristics
- Scale-driven — payroll is only 12% of revenue; the cost base is assets, not headcount
- Deep strategic-buyer pool — 171 firms exceed 500 employees, so a scaled asset has trade buyers
- Tight oligopoly vertically integrated with insurers.
- At the center of drug-pricing flows.
- Rebate/spread models under intense regulatory scrutiny.
NAICS 524292. U.S. Census Bureau — 2022 Statistics of U.S. Businesses; U.S. Census Bureau — 2022 Economic Census.
M&A deal context
Who’s acquiring
- Integrated payer-PBMs
- Transparent-PBM challengers
- Health-services strategics
What’s driving deals
- Vertical integration with payers and pharmacy.
- Regulatory and reform scrutiny reshaping the model.
- Transparent-PBM challengers entering the market.
Verticals in this segment
Find Pharmacy Benefits Management (PBM) acquisition targets
Search Acquisera’s index for companies classified under Pharmacy Benefits Management (PBM) (4.9.7) and build a targeted deal pipeline.
Search companies